Investors are closely monitoring SCLX as it navigates through the headwinds that have led to this notable decline, seeking ...

Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

The Sacklers will no longer have liability protection from future lawsuits. The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial ...

AVERSA™ Fentanyl Advances Toward Commercialization Our lead product, AVERSA™ Fentanyl, is poised to become the world’s first abuse-deterrent opioid transdermal patch. We made significant ...